Ibrahim El- Bayoumy holds bachelor of medicine and surgery (Tanta faculty of medicine-Egypt,1989),then he earned his master degree in public health, preventive and social medicine (Tanta faculty of medicine-Egypt1996),and MD,PhD in public health ,preventive and social medicine 2003 from Tanta faculty of medicine-Egypt and McGill faculty of medicine –Montreal -Canada in division of clinical epidemiology in Royal Victoria hospital through double channel system as scholarship from ministry of education-Egypt.
Abstract
Two billion people, or one in three, have been infected with hepatitis B worldwide. Of these, about 260 million live with chronic hepatitis B. Each year about 900,000 people die from hepatitis B worldwide, and about 2,000 of these deaths occur in the United States. Hepatitis B is transmitted through blood and is 100 times more infectious than HIV. An estimated one billion infectious viruses are in one-fifth of a teaspoon of blood of an infected person, so exposure to even a minute amount, such as on a shared toothbrush can cause infection. Hepatitis B is sometimes referred to as the “silent epidemic” because most people who are infected do not experience any symptoms. Liver cancer is the fourth leading cause of cancer deaths throughout the world, behind lung, colorectal and stomach cancers. Almost half of liver cancers are caused by chronic infection with hepatitis B. The World Health Organization (WHO) recommends the inclusion of hepatitis B vaccine in immunization programs of all countries; in 2017, about 8 of 10 infants born throughout the world received three doses of hepatitis B vaccine.